🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery

At the 2026 JPM Pharma conference, Chai Discovery, backed by OpenAI and valued at $4B, emerged as a key player in AI-powered drug discovery tools. Their advancements have reached a trust level enabling pharma teams to scale and innovate drug design, including complex antibody engineering.